ReviewPharmacogenomics and personalized medicine2014

Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide.

Loredana Serpe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.